Artivion, Inc. (AORT) Investor Relations Documents

Artivion, Inc. (AORT) investor relations documents from the company's IR site: 2 presentations, 11 press releases; latest deck 2026-08-06. Read in-app with summaries. First-party data.

2Q 2026 Earnings Presentation — Artivion's Q2 2026 earnings presentation highlights 11.3% GAAP revenue growth to $125.8M, driven by strong performance in On-X and stent grafts, and reiterates FY26 guidance.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06Press releaseArtivion Reports Second Quarter 2026 Financial Results
2026-08-06Earnings deck2Q 2026 Earnings Presentation
2026-07-28Press releaseArtivion to Participate in Upcoming Investor Conferences
2026-07-23Press releaseArtivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results
2026-06-29Press releaseArtivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
2026-06-10Press releaseArtivion to Participate in the 2026 Truist Securities MedTech Conference
2026-05-18Press releaseArtivion Completes Acquisition of Endospan Ltd.
2026-05-07Press releaseArtivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan
2026-04-23Press releaseArtivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results
2026-04-07Press releaseArtivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
2026-03-03Press releaseArtivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
2026-02-02Press releaseArtivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd
2022-11-08Investor meetingArtivion to Participate in Upcoming Investor Conferences

AORT overview · AORT earnings · AORT financials · AORT KPIs · AORT ownership · AORT peers · AORT filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.